71. A 25-year-old woman presents with schizophrenia-like symptoms caused by a drug. Which drug class is most likely responsible?

Answer: B

Explanation:

A dopamine agonist, such as amphetamine

Dopamine agonists, particularly amphetamines, can induce symptoms similar to schizophrenia due to their stimulating effects on the dopamine system. This class of drugs is known to increase dopaminergic activity, which can lead to psychotic symptoms.

A) An opioid antagonist, such as naloxone

Opioid antagonists like naloxone primarily block the effects of opioids and do not typically influence dopamine levels in a way that would cause schizophrenia-like symptoms. Therefore, they are unlikely to be responsible for such a presentation.

B) A dopamine agonist, such as amphetamine

This option is correct because amphetamines increase dopamine release and activity in the brain, which can lead to symptoms that mimic schizophrenia, including hallucinations and delusions. The mechanism of action directly correlates with the presentation of the symptoms.

C) Birth-control pills with estradiol

While hormonal changes may have various psychological effects, birth-control pills with estradiol are not associated with inducing schizophrenia-like symptoms. Their primary function is to regulate hormonal levels rather than affect dopamine pathways significantly.

D) An antipsychotic that is a dopamine antagonist

Antipsychotics are designed to reduce dopamine activity, which would typically alleviate rather than cause schizophrenia-like symptoms. Thus, this class of medication is not responsible for inducing such symptoms.

E) An herbal supplement with oxytocin

Oxytocin, while involved in social bonding and emotional regulation, does not directly cause schizophrenia-like symptoms. An herbal supplement containing oxytocin would not be expected to induce such psychotic features.

Conclusion

The evidence strongly supports that dopamine agonists, specifically amphetamines, can lead to the development of schizophrenia-like symptoms due to their enhancement of dopaminergic activity. All other options either do not influence dopamine in a relevant manner or counteract the symptoms associated with schizophrenia, making them less likely to be responsible for the observed condition.